Comprehensive Curriculum Overview for Drug Regulatory Affairs Program
The curriculum for the Drug Regulatory Affairs program at Ramanand Institute Of Pharmacy And Management Haridwar is structured to provide students with a holistic understanding of regulatory processes, compliance mechanisms, and ethical frameworks governing pharmaceutical products. The program spans eight semesters and integrates foundational sciences with specialized regulatory knowledge through a carefully curated sequence of core courses, departmental electives, science electives, and laboratory practicals.
SEMESTER | COURSE CODE | COURSE TITLE | CREDIT STRUCTURE (L-T-P-C) | PREREQUISITES |
---|---|---|---|---|
Semester I | PH101 | Chemistry for Pharmacy I | 3-0-2-4 | - |
PH102 | Biology for Pharmacy I | 3-0-2-4 | - | |
PH103 | Physics for Pharmacy I | 3-0-2-4 | - | |
PH104 | Mathematics I | 3-0-2-4 | - | |
PH105 | English Communication Skills | 2-0-0-2 | - | |
PH106 | Introduction to Pharmaceutical Sciences | 3-0-2-4 | - | |
PH107 | Computer Applications in Pharmacy | 2-0-2-3 | - | |
PH108 | Pharmaceutical Ethics and Professionalism | 2-0-0-2 | - | |
PH109 | Introduction to Regulatory Affairs | 2-0-0-2 | - | |
PH110 | Pharmaceutical Chemistry I | 3-0-2-4 | - | |
PH111 | Pharmacology I | 3-0-2-4 | - | |
PH112 | Toxicology I | 3-0-2-4 | - | |
PH113 | Pharmaceutical Calculations | 2-0-0-2 | - | |
PH114 | Chemistry Lab I | 0-0-6-2 | - | |
PH115 | Biology Lab I | 0-0-6-2 | - | |
Semester II | PH201 | Chemistry for Pharmacy II | 3-0-2-4 | PH101 |
PH202 | Biology for Pharmacy II | 3-0-2-4 | PH102 | |
PH203 | Physics for Pharmacy II | 3-0-2-4 | PH103 | |
PH204 | Mathematics II | 3-0-2-4 | PH104 | |
PH205 | Organic Chemistry I | 3-0-2-4 | - | |
PH206 | Pharmacology II | 3-0-2-4 | PH111 | |
PH207 | Toxicology II | 3-0-2-4 | PH112 | |
PH208 | Pharmaceutical Analysis I | 3-0-2-4 | - | |
PH209 | Pharmaceutical Chemistry II | 3-0-2-4 | PH110 | |
PH210 | Medicinal Chemistry I | 3-0-2-4 | - | |
PH211 | Pharmacognosy I | 3-0-2-4 | - | |
PH212 | Pharmaceutical Technology I | 3-0-2-4 | - | |
PH213 | Pharmacology Lab I | 0-0-6-2 | PH206 | |
PH214 | Chemistry Lab II | 0-0-6-2 | PH201 | |
PH215 | Biology Lab II | 0-0-6-2 | PH202 | |
Semester III | PH301 | Pharmacology III | 3-0-2-4 | PH206 |
PH302 | Pharmaceutical Chemistry III | 3-0-2-4 | PH209 | |
PH303 | Medicinal Chemistry II | 3-0-2-4 | PH210 | |
PH304 | Pharmacognosy II | 3-0-2-4 | PH211 | |
PH305 | Pharmaceutical Technology II | 3-0-2-4 | PH212 | |
PH306 | Pharmaceutical Analysis II | 3-0-2-4 | PH208 | |
PH307 | Pharmacology Lab II | 0-0-6-2 | PH301 | |
PH308 | Chemistry Lab III | 0-0-6-2 | PH214 | |
PH309 | Biology Lab III | 0-0-6-2 | PH215 | |
PH310 | Pharmaceutical Chemistry Lab I | 0-0-6-2 | PH209 | |
PH311 | Pharmacognosy Lab I | 0-0-6-2 | PH304 | |
PH312 | Medicinal Chemistry Lab I | 0-0-6-2 | PH303 | |
PH313 | Pharmaceutical Technology Lab I | 0-0-6-2 | PH305 | |
PH314 | Regulatory Affairs I | 2-0-0-2 | - | |
PH315 | Pharmacovigilance Fundamentals | 2-0-0-2 | - | |
Semester IV | PH401 | Pharmacology IV | 3-0-2-4 | PH301 |
PH402 | Pharmaceutical Chemistry IV | 3-0-2-4 | PH302 | |
PH403 | Medicinal Chemistry III | 3-0-2-4 | PH303 | |
PH404 | Pharmacognosy III | 3-0-2-4 | PH304 | |
PH405 | Pharmaceutical Technology III | 3-0-2-4 | PH305 | |
PH406 | Pharmaceutical Analysis III | 3-0-2-4 | PH306 | |
PH407 | Regulatory Affairs II | 2-0-0-2 | PH314 | |
PH408 | Good Manufacturing Practices (GMP) | 2-0-0-2 | - | |
PH409 | Good Clinical Practices (GCP) | 2-0-0-2 | - | |
PH410 | Pharmacovigilance Advanced | 2-0-0-2 | PH315 | |
PH411 | Regulatory Writing and Documentation | 2-0-0-2 | - | |
PH412 | Quality Assurance Systems | 2-0-0-2 | - | |
PH413 | Pharmacology Lab III | 0-0-6-2 | PH401 | |
PH414 | Chemistry Lab IV | 0-0-6-2 | PH308 | |
PH415 | Biology Lab IV | 0-0-6-2 | PH309 | |
Semester V | PH501 | Regulatory Affairs III | 2-0-0-2 | PH407 |
PH502 | Biologics and Advanced Therapies Regulation | 2-0-0-2 | - | |
PH503 | Clinical Research Regulation | 2-0-0-2 | - | |
PH504 | Global Regulatory Strategy | 2-0-0-2 | - | |
PH505 | Post-Market Surveillance Regulation | 2-0-0-2 | - | |
PH506 | Regulatory Affairs in Emerging Technologies | 2-0-0-2 | - | |
PH507 | Pharmaceutical Quality Assurance Regulation | 2-0-0-2 | - | |
PH508 | Pediatric Drug Development Regulation | 2-0-0-2 | - | |
PH509 | Regulatory Compliance Audits | 2-0-0-2 | - | |
PH510 | International Drug Approval Process | 2-0-0-2 | - | |
PH511 | Regulatory Risk Management | 2-0-0-2 | - | |
PH512 | Pharmacovigilance Systems | 2-0-0-2 | PH410 | |
PH513 | Regulatory Affairs Case Studies | 2-0-0-2 | - | |
PH514 | Regulatory Affairs Workshop | 0-0-6-2 | - | |
PH515 | Mini Project I | 0-0-6-2 | - | |
Semester VI | PH601 | Regulatory Affairs IV | 2-0-0-2 | PH501 |
PH602 | Advanced Clinical Trial Design | 2-0-0-2 | - | |
PH603 | Regulatory Affairs in Digital Health | 2-0-0-2 | - | |
PH604 | Regulatory Affairs for Orphan Drugs | 2-0-0-2 | - | |
PH605 | Regulatory Affairs in Vaccine Development | 2-0-0-2 | - | |
PH606 | International Harmonization Efforts | 2-0-0-2 | - | |
PH607 | Regulatory Ethics and Governance | 2-0-0-2 | - | |
PH608 | Pharmacovigilance Data Management | 2-0-0-2 | PH512 | |
PH609 | Regulatory Affairs for Personalized Medicine | 2-0-0-2 | - | |
PH610 | Global Regulatory Compliance Trends | 2-0-0-2 | - | |
PH611 | Regulatory Affairs in Emerging Markets | 2-0-0-2 | - | |
PH612 | Regulatory Affairs Capstone Project | 0-0-6-2 | - | |
PH613 | Mini Project II | 0-0-6-2 | PH515 | |
PH614 | Regulatory Affairs Internship | 0-0-12-2 | - | |
PH615 | Research Methodology | 2-0-0-2 | - | |
Semester VII | PH701 | Regulatory Affairs V | 2-0-0-2 | PH601 |
PH702 | Regulatory Affairs in Public Health | 2-0-0-2 | - | |
PH703 | Advanced Pharmacovigilance | 2-0-0-2 | PH608 | |
PH704 | Regulatory Affairs in Biotechnology | 2-0-0-2 | - | |
PH705 | Regulatory Affairs for Medical Devices | 2-0-0-2 | - | |
PH706 | Pharmaceutical Patent Law | 2-0-0-2 | - | |
PH707 | Regulatory Affairs for Combination Products | 2-0-0-2 | - | |
PH708 | Regulatory Affairs for Biosimilars | 2-0-0-2 | - | |
PH709 | Regulatory Affairs in Global Health Policy | 2-0-0-2 | - | |
PH710 | Regulatory Affairs for Rare Diseases | 2-0-0-2 | - | |
PH711 | Regulatory Affairs in Pharmacogenomics | 2-0-0-2 | - | |
PH712 | Regulatory Affairs for Digital Therapeutics | 2-0-0-2 | - | |
PH713 | Regulatory Affairs Capstone Project II | 0-0-6-2 | PH612 | |
PH714 | Mini Project III | 0-0-6-2 | PH613 | |
PH715 | Thesis Proposal | 0-0-6-2 | - | |
Semester VIII | PH801 | Regulatory Affairs VI | 2-0-0-2 | PH701 |
PH802 | Advanced Topics in Regulatory Affairs | 2-0-0-2 | - | |
PH803 | Regulatory Affairs and Innovation | 2-0-0-2 | - | |
PH804 | Regulatory Affairs for Global Supply Chains | 2-0-0-2 | - | |
PH805 | Regulatory Affairs in Artificial Intelligence | 2-0-0-2 | - | |
PH806 | Regulatory Affairs for Precision Medicine | 2-0-0-2 | - | |
PH807 | Regulatory Affairs and Climate Change | 2-0-0-2 | - | |
PH808 | Regulatory Affairs in Emerging Markets | 2-0-0-2 | - | |
PH809 | Regulatory Affairs for Health Technology Assessment | 2-0-0-2 | - | |
PH810 | Regulatory Affairs and Public Policy | 2-0-0-2 | - | |
PH811 | Regulatory Affairs for Mental Health | 2-0-0-2 | - | |
PH812 | Regulatory Affairs in Global Health Security | 2-0-0-2 | - | |
PH813 | Thesis Writing and Presentation | 0-0-6-2 | PH715 | |
PH814 | Regulatory Affairs Thesis | 0-0-12-4 | PH813 | |
PH815 | Final Internship | 0-0-12-2 | - |
Detailed Course Descriptions for Advanced Departmental Electives
The Drug Regulatory Affairs program at Ramanand Institute Of Pharmacy And Management Haridwar offers a range of advanced departmental elective courses designed to deepen students' understanding of specialized areas within regulatory affairs. These courses are taught by leading experts in their respective fields and provide insights into emerging trends, practical applications, and cutting-edge research.
Biologics and Advanced Therapies Regulation
This course explores the unique regulatory challenges associated with complex biological products such as vaccines, gene therapies, cell-based treatments, and recombinant proteins. Students will learn about specialized manufacturing requirements, quality control measures, safety monitoring protocols, and approval pathways for biologics in various global markets.
Clinical Research Regulation
Focused on the regulatory aspects of clinical research, this course covers topics such as investigational new drug (IND) applications, informed consent processes, data integrity requirements, and ethical considerations in clinical trials. Students will also study international guidelines for conducting clinical research and managing trial risks.
Post-Market Surveillance Regulation
This course focuses on monitoring drugs after they enter the market, covering adverse event reporting systems, risk management plans, pharmacovigilance strategies, and safety signal detection. Students will learn how to develop and implement surveillance programs that ensure continued safety and efficacy of approved products.
Global Regulatory Strategy
Designed for students interested in international drug regulation, this course covers regulatory harmonization efforts, cross-border compliance issues, and strategic planning required to launch drugs in multiple jurisdictions simultaneously. It includes case studies on successful global launches and regulatory challenges faced by multinational companies.
Pharmaceutical Quality Assurance Regulation
This course focuses on ensuring pharmaceutical products meet quality standards throughout their lifecycle, covering quality systems, batch release procedures, compliance with international quality guidelines, and risk-based approaches to quality management in regulated environments.
Pediatric Drug Development Regulation
Specializing in regulatory requirements for medicines intended for children, this course covers ethical considerations, dosing studies, special protocols required for pediatric formulations, and unique regulatory pathways for rare diseases. Students will also explore incentives provided by regulatory agencies to encourage pediatric drug development.
Regulatory Affairs in Emerging Technologies
This cutting-edge course explores the regulatory landscape for novel therapeutic approaches such as personalized medicine, digital therapeutics, artificial intelligence in drug development, and blockchain applications in pharmaceutical supply chains. Students will learn how emerging technologies impact traditional regulatory paradigms and how new frameworks are being developed to address these innovations.
Regulatory Affairs for Orphan Drugs
Focused on rare disease treatments, this course covers the regulatory incentives provided by various agencies for orphan drug development, including expedited approval pathways, market exclusivity periods, and financial support mechanisms. Students will also study challenges in conducting clinical trials for rare diseases and navigating regulatory requirements.
Regulatory Affairs for Vaccine Development
This course provides comprehensive coverage of vaccine regulatory processes, including preclinical development, clinical trial design, manufacturing standards, and approval pathways for vaccines. Students will explore the unique challenges of vaccine regulation, including safety monitoring, immunogenicity testing, and global harmonization efforts.
Regulatory Affairs for Medical Devices
Designed for students interested in medical device regulation, this course covers classification systems, premarket approval processes, post-market surveillance requirements, and quality management standards. Students will learn how regulatory frameworks differ between devices and drugs and gain practical experience in preparing device-related regulatory submissions.
Project-Based Learning Philosophy
The department's philosophy on project-based learning is rooted in the belief that real-world problem-solving skills are essential for success in the field of regulatory affairs. This approach emphasizes hands-on engagement with actual regulatory challenges, allowing students to apply theoretical knowledge in practical contexts.
The structure of our project-based learning framework involves three major phases: mini-projects, capstone projects, and thesis research. Mini-projects are introduced in the third year and focus on specific regulatory topics such as preparing a regulatory submission for a hypothetical drug or conducting a risk assessment for a pharmaceutical product.
Capstone projects in the final year involve extensive work on real-world regulatory challenges, often sponsored by industry partners. Students work closely with faculty mentors to develop comprehensive solutions that demonstrate their ability to navigate complex regulatory environments.
The evaluation criteria for these projects emphasize critical thinking, analytical skills, regulatory knowledge application, and professional presentation abilities. Students are assessed not only on the technical quality of their work but also on their ability to communicate complex regulatory concepts effectively to both scientific and non-scientific audiences.
Project selection is guided by student interests, faculty expertise, and current industry trends. Faculty mentors are assigned based on their area of specialization and relevance to the chosen project topic. This mentorship system ensures that students receive guidance from experts who can provide insights into both academic rigor and industry relevance.